Tumor Intracellular Bioavailability of Doxorubicin Determines Therapeutic Efficacy of GLP Grade Nanoparticle Targeted to Nucleolin
2020.3.4
Nuno Fonseca
CNC
Human Metabolic Studies that Led to the Submission of an NIH R01
2020.3.3
Eugénia Carvalho
CNC, University of Coimbra & University of Arkansas for Medical Sciences
Vector B2B - the Service Provider for Drug Discovery and Development in Portugal
2020.2.28
Bebiana Sá Moura
Vector B2B - Drug Developing Association for Research in Biotechnology
Mathematical Modelling of Cell Movement and Angiogenesis
2020.2.28
Rui Travasso
CFisUC; Department of Physics, UC
Science Communication Through Design and Multimedia Projects
2020.2.21
Nuno Coelho
DEIUC and CEIS20
 
 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  »»  next  1 of 120   total: 5 of 597 registers
 
   
Financiado por Fundos FEDER através do Programa Operacional Factores de Competitividade – COMPETE 2020 e por Fundos Nacionais através da FCT – Fundação para a Ciência e a Tecnologia no âmbito do projecto Estratégico com referência atribuida pelo COMPETE: POCI-01-0145-FEDER-007440

© 2020 CNC - Center for Neuroscience and Cell Biology
powered by DigitalWind